Transcatheter Aortic Valve Replacement: a Kidney's Perspective.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 27069960)

Published in J Renal Inj Prev on January 18, 2016

Authors

Wisit Cheungpasitporn1, Charat Thongprayoon2, Kianoush Kashani3

Author Affiliations

1: Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
2: Department of Internal Medicine, Bassett Medical Center, Cooperstown, NY, USA.
3: Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.

Articles cited by this

Burden of valvular heart diseases: a population-based study. Lancet (2006) 8.94

The RIFLE criteria and mortality in acute kidney injury: A systematic review. Kidney Int (2007) 6.35

Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med (2014) 5.88

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2014) 4.34

5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet (2015) 4.01

The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. Ann Thorac Surg (2009) 3.45

Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation (2006) 2.88

Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg (2009) 2.87

5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet (2015) 2.43

Incidence and predictors of acute kidney injury after transcatheter aortic valve replacement. Am Heart J (2012) 2.33

One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation (2011) 1.98

Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J (2009) 1.81

Frequency, determinants, and prognostic effects of acute kidney injury and red blood cell transfusion in patients undergoing transcatheter aortic valve implantation. Catheter Cardiovasc Interv (2011) 1.80

2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement. J Am Coll Cardiol (2015) 1.75

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J (2012) 1.72

Renal impairment and transapical aortic valve implantation: impact of contrast medium dose on kidney function and survival. Eur J Cardiothorac Surg (2011) 1.58

Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation). JACC Cardiovasc Interv (2015) 1.44

Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study. JACC Cardiovasc Interv (2014) 1.41

Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation. JACC Cardiovasc Interv (2010) 1.41

Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement. Nephrol Dial Transplant (2009) 1.34

Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation. CMAJ (2005) 1.26

Epidemiology of acquired valvular heart disease. Can J Cardiol (2014) 1.23

The evolving epidemiology of valvular aortic stenosis. the Tromsø study. Heart (2012) 1.22

Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. EuroIntervention (2011) 1.22

Chronic kidney disease: an inherent risk factor for acute kidney injury? Clin J Am Soc Nephrol (2010) 1.20

Incidence and predictors of acute kidney injury in patients undergoing transcatheter aortic valve implantation. Am Heart J (2011) 1.19

The report of a national conference on the wait list for kidney transplantation. Am J Transplant (2003) 1.14

Acute kidney injury after transcatheter aortic valve replacement: a systematic review and meta-analysis. Am J Nephrol (2015) 1.10

Acute kidney injury after aortic valve replacement: incidence, risk factors and outcomes. Expert Rev Cardiovasc Ther (2015) 1.07

Incidence, risk factors and prognosis of acute kidney injury after transcatheter aortic valve implantation. Nephrology (Carlton) (2012) 0.98

Transcatheter vs surgical aortic valve replacement in intermediate-surgical-risk patients with aortic stenosis: a propensity score-matched case-control study. Am Heart J (2012) 0.97

Renal function-based contrast dosing predicts acute kidney injury following transcatheter aortic valve implantation. JACC Cardiovasc Interv (2013) 0.97

AKI after Transcatheter or Surgical Aortic Valve Replacement. J Am Soc Nephrol (2015) 0.96

Survival of kidney transplantation patients in the United States after cardiac valve replacement. Circulation (2010) 0.96

Risk of acute kidney injury after minimally invasive transapical aortic valve implantation in 270 patients. Eur J Cardiothorac Surg (2010) 0.94

Transcatheter aortic valve implantation or surgical aortic valve replacement as redo procedure after prior coronary artery bypass grafting. Ann Thorac Surg (2011) 0.93

Transcatheter versus surgical treatment for aortic stenosis: patient selection and early outcome. Scand Cardiovasc J (2012) 0.92

Acute kidney injury after transcatheter aortic valve implantation: incidence, predictors and impact on mortality. Arch Cardiovasc Dis (2014) 0.90

Comparison of surgically removed cardiac valves of patients with ESRD with those of the general population. Am J Kidney Dis (2005) 0.88

The effects of VARC-defined acute kidney injury after transcatheter aortic valve implantation (TAVI) using the Edwards bioprosthesis. EuroIntervention (2012) 0.88

Actual versus ideal body weight for acute kidney injury diagnosis and classification in critically ill patients. BMC Nephrol (2014) 0.88

Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and clinical outcome. Int J Cardiol (2012) 0.87

Transapical versus conventional aortic valve replacement--a propensity-matched comparison. Heart Surg Forum (2012) 0.87

Sniffing out acute kidney injury in the ICU: do we have the tools? Curr Opin Crit Care (2013) 0.87

Biomarkers for acute kidney injury: where are we today? Where should we go? Clin Chem (2013) 0.85

Optimum methodology for estimating baseline serum creatinine for the acute kidney injury classification. Nephrology (Carlton) (2015) 0.85

Acute kidney injury after transcatheter aortic valve implantation. J Thorac Dis (2015) 0.83

Transapical minimally invasive aortic valve implantation and conventional aortic valve replacement in octogenarians. Thorac Cardiovasc Surg (2012) 0.82

Improvement in renal functions with transcatheter aortic valve implantation. J Geriatr Cardiol (2013) 0.82

Transcatheter aortic valve implantation improves outcome compared to open-heart surgery in kidney transplant recipients requiring aortic valve replacement. J Cardiol (2013) 0.82

Doppler-based renal resistance index for the detection of acute kidney injury and the non-invasive evaluation of paravalvular aortic regurgitation after transcatheter aortic valve implantation. EuroIntervention (2014) 0.80

Periprocedural effects of statins on the incidence of contrast-induced acute kidney injury: a systematic review and meta-analysis of randomized controlled trials. Ren Fail (2015) 0.80

Effect of severe left ventricular systolic dysfunction on hospital outcome after transcatheter aortic valve implantation or surgical aortic valve replacement: results from a propensity-matched population of the Italian OBSERVANT multicenter study. J Thorac Cardiovasc Surg (2013) 0.79

Chronic kidney disease is not associated with a higher risk for mortality or acute kidney injury in transcatheter aortic valve implantation. Nephrol Dial Transplant (2012) 0.79

Transcatheter aortic valve implantation - what the general physician needs to know. Clin Med (2015) 0.78

Transcatheter vs. surgical aortic valve replacement: a retrospective analysis assessing clinical effectiveness and safety. J Cardiovasc Med (Hagerstown) (2012) 0.78

TAVI in 2015: who, where and how? Heart (2015) 0.78

Impact of kidney function on mortality after transcatheter valve implantation in patients with severe aortic valvular stenosis. Int J Cardiol (2014) 0.77

Transcatheter aortic valve implantation in end-stage renal disease. Clin Kidney J (2012) 0.76

Transcatheter and Surgical Aortic Valve Replacement in Dialysis Patients: A Propensity-Matched Comparison. Ann Thorac Surg (2015) 0.76

Aortic root rupture after TAVR in two renal transplant patients on chronic immunosuppressant therapy. Catheter Cardiovasc Interv (2014) 0.76

Prevention of Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation). JACC Cardiovasc Interv (2015) 0.76

Recent advances in transcatheter aortic valve replacement for high-risk patients. Expert Rev Cardiovasc Ther (2015) 0.76

Articles by these authors

Risk of venous thromboembolism among patients with vasculitis: a systematic review and meta-analysis. Clin Rheumatol (2016) 1.39

Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: A systematic review and meta-analysis of observational studies. Eur J Intern Med (2015) 0.98

Hepatitis C infection and intrahepatic cholestasis of pregnancy: A systematic review and meta-analysis. Clin Res Hepatol Gastroenterol (2016) 0.78

The options of reversal of a dabigatran effect. Am J Emerg Med (2015) 0.75

Diagnosis and treatment of eosinophilic colitis complicated with renal infarction. Am J Emerg Med (2015) 0.75

Hepatitis B virus infection and risk of coronary artery disease: a meta-analysis. Ann Transl Med (2016) 0.75

The impact of frailty on mortality after transcatheter aortic valve replacement. Ann Transl Med (2017) 0.75

Hepatitis C Virus Infection and Risk of Venous Thromboembolism: A Systematic Review and Meta-Analysis. Ann Hepatol (2017) 0.75

Association between coffee consumption and risk of renal cell carcinoma: A Meta-analysis. Intern Med J (2017) 0.75

Association of coffee consumption and chronic kidney disease: A meta-analysis. Int J Clin Pract (2016) 0.75

Association between Urologic Malignancies and End-stage Renal Disease: A Meta-Analysis. Nephrology (Carlton) (2017) 0.75

Hyperuricemia and Risk of Nonalcoholic Fatty Liver Disease: A Meta-analysis. Liver Int (2016) 0.75

Hepatitis C virus infection and risk of gallstones: A meta-analysis. J Evid Based Med (2017) 0.75

Updates on the risk factors of acute kidney injury after transcatheter aortic valve replacement. J Renal Inj Prev (2016) 0.75

Celiac disease and the risk of kidney diseases: A systematic review and meta-analysis. Dig Liver Dis (2016) 0.75

Efficacy and Safety of Direct-acting Antivirals in Hepatitis C Virus-infected Patients Taking Proton Pump Inhibitors. J Clin Transl Hepatol (2017) 0.75

Lymphomatoid granulomatosis mimicking vasculitis. Ann Hematol (2015) 0.75

Characteristics and Outcomes of Fasting Orders Among Medical Inpatients. J Hosp Med (2017) 0.75

Non-ischemic cardiomyopathy after rituximab treatment for membranous nephropathy. J Renal Inj Prev (2016) 0.75